MedPath

成都市海通药业有限公司

Ownership
-
Established
2010-12-07
Employees
-
Market Cap
-
Website
http://www.hepatunn.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

66

NMPA:66

Drug Approvals

Torasemide Injection

Product Name
托拉塞米注射液
Approval Number
国药准字H20247243
Approval Date
Oct 17, 2024
NMPA

Citicoline Injection

Product Name
胞磷胆碱注射液
Approval Number
国药准字H20243523
Approval Date
Apr 17, 2024
NMPA

Norfloxacin Lactate Injection

Product Name
乳酸诺氟沙星注射液
Approval Number
国药准字H20093483
Approval Date
Nov 30, 2023
NMPA

Norfloxacin Lactate Injection

Product Name
乳酸诺氟沙星注射液
Approval Number
国药准字H20093484
Approval Date
Nov 30, 2023
NMPA

Tranexamic Acid Injection

Product Name
氨甲环酸注射液
Approval Number
国药准字H20234559
Approval Date
Nov 28, 2023
NMPA

Thioctic Acid Injection

Product Name
硫辛酸注射液
Approval Number
国药准字H20234517
Approval Date
Nov 21, 2023
NMPA

Levofloxacin Injection

Product Name
左氧氟沙星注射液
Approval Number
国药准字H20223628
Approval Date
Aug 30, 2022
NMPA

Torasemide Injection

Product Name
托拉塞米注射液
Approval Number
国药准字H20223626
Approval Date
Aug 30, 2022
NMPA

Methionine and Vitamin B1 Injection

Product Name
甲硫氨酸维B1注射液
Approval Number
国药准字H20066140
Approval Date
Sep 6, 2021
NMPA

Methionine and Vitamin B1 Injection

Product Name
甲硫氨酸维B1注射液
Approval Number
国药准字H20066139
Approval Date
Sep 6, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.